跳至主要内容
临床试验/NCT05620173
NCT05620173进行中(未招募)不适用

'Validation and Development of New Dichoptic VR-gaming Method to Treat Childhood Amblyopia; Vedea Amblyopia Therapy (VAT)

Vedea Healthware BV4 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2023年2月22日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
74
试验地点
4
主要终点
Change from baseline in Visual Acuity measured in LogMAR lines

研究概览

简要总结

The purpose of this clinical study is to validate the effectiveness of the Vedea Amblyopia Therapy (VAT) as a treatment for children with lazy eye.

The main question it aims to answer is to prove that the VAT is as effective or more effective than the current gold standard for treating children with lazy eye. This is occlusion therapy by patching the dominant eye.

Participants will play VR-games specifically designed for children with lazy eye for 30 minutes per day, 5 days per week for 16 weeks. This group of children will be compared to children that undergo regular occlusion therapy to see how both treatments options compare.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
4 Years 至 10 Years(Child)
性别
All
接受健康志愿者

入选标准

  • wearing the full corrected refraction for ≥14 weeks to adapt to the glasses
  • diagnosed with an unilateral anisometropic, strabismic and/or deprivation amblyopia.
  • Amblyopia was defined as an intraocular difference (IOD) in visual acuity (VA) of 0.2 log MAR (2 lines) or more. Angle of strabismus ≤ 10 prism diopters at near and distance fixation. Current clear media (in case of deprivation amblyopia after successful surgery).
  • currently under treatment or starting treatment for unilateral amblyopia
  • participants must have easy access to an Android device equal to or higher than a Samsung Galaxy S8
  • written informed consent by parents or legal guardians

排除标准

  • current treatment with atropine penalisation
  • documented history of severe negative side effects that occur with exposure to VR usage (eg. seizures or epileptic spasms)
  • photosensitivity
  • no developmental delay
  • coexisting ocular pathology or systemic diseases

结局指标

主要结局

Change from baseline in Visual Acuity measured in LogMAR lines

时间窗: Each clinical visit (approximately 1 month)

The LogMAR method is a validated and often used method of measuring visual acuity in children (with or without amblyopia). Possible scores range from 0 (perfect vision) to 1.0 or higher as really bad vision.

次要结局

  • Treatment adherence to the VAT defined as time played per day(Daily registration of time played up to week 16)
  • Rate of change in visual acuity outcomes(Each clinical visit (approximately 1 month))

研究者

发起方
Vedea Healthware BV
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验